{"url_path":"/sec/nvct/proxy/2026-04-27/000110465926049480","section_key":"body","section_title":"DEFA14A body","topic":"sec","document":{"doc_type":"DEFA14A","doc_date":"2026-04-27","source_url":"https://www.sec.gov/Archives/edgar/data/1875558/0001104659-26-049480-index.html","accession_number":"0001104659-26-049480","cik":"0001875558","ticker":"NVCT","issuer_name":"Nuvectis Pharma, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1875558/0001104659-26-049480-index.html","primary_entity_key":"0001875558","primary_entity_name":"Nuvectis Pharma, Inc."},"word_count":479,"has_tables":true,"body_markdown":"DEFA14A\n1\ntm261542d3_defa14a.htm\nDEFA14A\n\n** **\n\n**UNITED STATES**\n\n**SECURITIES AND EXCHANGE COMMISSION**\n\n**Washington, D.C. 20549**\n\n**SCHEDULE 14A INFORMATION**\n\n**Proxy Statement Pursuant to Section 14(a) of\nthe\nSecurities Exchange Act of 1934\n(Amendment No. _____)**\n\nFiled by the Registrant\nx\n\nFiled by a Party other than the Registrant\n¨\n\nCheck the appropriate box:\n\n¨\nPreliminary Proxy Statement\n\n¨\nConfidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))\n\n¨\nDefinitive Proxy Statement\n\nx\nDefinitive Additional Materials\n\n¨\nSoliciting Material under Rule14a-12\n\n**NUVECTIS\nPHARMA, INC.**\n\n(Name of Registrant as Specified In Its Charter)\n\n(Name of Person(s) Filing Proxy Statement,\nif other than the Registrant)\n\nPayment of Filing Fee (Check all boxes that apply):\n\nx\nNo fee required.\n\n¨\nFee paid previously with preliminary materials.\n\n¨\nFee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.\n\nSmartphone users\nPoint your camera here and\nvote without entering a\ncontrol number\nFor complete information and to vote, visit www.ProxyVote.com\nControl #\nV95528-P46879\nYour Vote Counts!\nNUVECTIS PHARMA, INC.\n2026 Annual Meeting\nVote by June 10, 2026\n11:59 PM ET\nYou invested in NUVECTIS PHARMA, INC. and it’s time to vote!\nYou have the right to vote on proposals being presented at the Annual Meeting. This is an important notice regarding the\navailability of proxy materials for the stockholder meeting to be held on June 11, 2026.\nVote Virtually at the Meeting*\nJune 11, 2026\n10:00 AM, EDT\nVirtually at:\nwww.virtualshareholdermeeting.com/NVCT2026\n*Please check the meeting materials for any special requirements for meeting attendance.\nGet informed before you vote\nView the Notice and Proxy Statement and Form 10-K online OR you can receive a free paper or email copy of the material(s) by\nrequesting prior to May 28, 2026. If you would like to request a copy of the material(s) for this and/or future stockholder meetings,\nyou may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to sendmaterial@proxyvote.com. If sending an\nemail, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a\npaper or email copy.\nNUVECTIS PHARMA, INC.\n1 BRIDGE PLAZA, SUITE 275\nFORT LEE, NJ 07024\nATTN: MICHAEL CARSON\n\nTHIS IS NOT A VOTABLE BALLOT\nThis is an overview of the proposals being presented at the\nupcoming stockholder meeting. Please follow the instructions on\nthe reverse side to vote these important matters.\nVote at www.ProxyVote.com\nPrefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click “Delivery Settings”.\nVoting Items\nBoard\nRecommends\nV95529-P46879\n1. Election of Director.\nNominee:\n1a. Ron Bentsur For\n2. Ratify the appointment of Kesselman & Kesselman, a member firm of PricewaterhouseCoopers International Limited,\nas our independent registered public accounting firm for the year ending December 31, 2026. For\nNOTE: Transact any other business that may properly come before the Annual Meeting or any adjournment of the Annual\nMeeting."}